HCPLive Network

Atrial Fibrillation

Preliminary research suggests that optogenetics could eventually replace electric shocks in the treatment of atrial fibrillation.
When patients with diabetes or metabolic syndrome experience acute cardiac events, the subject of stents often arises.
Two randomized controlled studies have found that continuous monitoring of patients after cryptogenic strokes can detect several times as many cases of atrial fibrillation as conventional monitoring.
Phase II trial data suggest that a fixed-dose combination of ranolazine and low-dose dronedarone may significantly reduce disease burden among patients with atrial fibrillation.
For patients with ischemic stroke or transient ischemic attack, electrocardiogram (ECG) monitoring with a 30-day event-triggered recorder improves detection of atrial fibrillation, according to a study published June 26 in the New England Journal of Medicine.
New research financed by Medtronic Inc. suggests that implantable cardiac resynchronization therapy devices governed by its new algorithms may reduce atrial fibrillation-related complications in patients who have experienced heart failure.
Atrial Fibrillation Resources